Data Bridge Market Research analyses that the Tularemia Therapeutics Market was valued at USD 155 million in 2021 and is expected to reach USD 170.52 million by 2029, registering a CAGR of 1.20% during the forecast period of 2022 to 2029.
Industry Analysis
Tularemia has a low overall fatality rate of less than 2% but a high mortality rate of up to 24 percent depending on the strain, as per...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian